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Background: Computerized cognitive bias modification for social anxiety disorder has in several well conducted
trials shown great promise with as many as 72% no longer fulfilling diagnostic criteria after a 4 week training
program. To test if the same program can be transferred from a clinical setting to an internet delivered home
based treatment the authors conducted a randomized, double-blind placebo-controlled trial.
Methods: After a diagnostic interview 79 participants were randomized to one of two attention training programs
using a probe detection task. In the active condition the participant was trained to direct attention away from
threat, whereas in the placebo condition the probe appeared with equal frequency in the position of the
threatening and neutral faces.
Results: Results were analyzed on an intention-to-treat basis, including all randomized participants. Immediate and
4-month follow-up results revealed a significant time effect on all measured dimensions (social anxiety scales,
general anxiety and depression levels, quality of life). However, there were no time x group interactions. The lack of
differences in the two groups was also mirrored by the infinitesimal between group effect size both at post test
and at 4-month follow-up.
Conclusion: We conclude that computerized attention bias modification may need to be altered before
dissemination for the Internet.
Trial registration: ISRCTN01715124
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A recent development in the treatment of anxiety disor-
ders is attention bias modification [1], which derives
from basic research on information processing of threat
relevant stimuli in various conditions such as social anx-
iety disorder [2]. There is an extensive literature on the
link between attention and anxiety [3] and this link
appears to be causal [4,5]. Attentional bias for threat in
social anxiety is commonly measured using the probe
detection task [6-8]. In the probe detection task [9] (for* Correspondence: per@carlbring.se
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reproduction in any medium, provided the ora review, see)[10], participants see a pair of faces at two
different spatial locations on a screen. One of the faces
is threatening, the other face is neutral. After the offset
of these faces, a probe appears replacing the threatening
face (congruent presentation) or neutral face stimulus
(incongruent presentation). Faster responses to detect
probes replacing threat faces than probes replacing neu-
tral faces is used as an index of attentional bias toward
threat relevant information.
Moreover, there is evidence that successful treatment for
social phobia may lead to a normalization of attention bias
for threat [11]. This finding is consistent with the view that
attention bias to threat-relevant information plays a role inal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ary findings, MacLeod and colleagues [12] reported the first
study to train attention and examine its effect on anxiety.
These researchers found that participants in the Attend
Threat condition showed faster response latencies for
detecting probes following threat words than neutral words.
Participants in the Attend Neutral condition showed the
opposite pattern of results. Moreover, this training extended
to word pairs containing novel threat-relevant words and
was not confined to specifically trained word pairs. Finally,
participants in the Attend Threat condition responded
more negatively to the experimental stressor than did those
in the Attend Neutral condition. Extending this research,
investigators have examined the effect of attention training
in clinical populations. Recent reviews [4,5,13] suggest that
attention training can be effective in in reducing anxiety in
clinical and non-clinical population.
In a meta-analysis on the effects of attention bias
modification by Hakamata and coworkers [14], 10 ran-
domized controlled trials were identified including 467
participants. The average between group effect size was
d = 0.61 on anxiety measures, and effects could be estab-
lished up to 4 months after treatment termination. How-
ever, effect sizes differed widely between the studies, but
a strength in this research is the possibility to have an
active placebo control condition [5].
Attention bias modification is a potentially effective com-
puterized treatment that most often has been delivered in a
laboratory setting with subclinical samples e.g., [15]. The
training can sometimes be as short as one session with a
total of 128 stimulus pairings [16]. The treatment involves
repeatedly redirecting attention away from socially relevant
threat cues in order to induce preferential selective proces-
sing of neutral (non-threat) stimuli [17]. Up until recently
few studies on attention bias modification have targeted
clinical populations of people suffering from social anxiety.
One exception is a study in which 44 participants with gen-
eralized social phobia were randomized to one of two com-
puterized attention bias modification programs [17]. Both
conditions used a combination of faces expressing neutral
and/or disgust emotions. After practicing twice a week dur-
ing 4 weeks – equaling approximately 160 minutes in total
– half of the participants in the treatment group as com-
pared to 14% in the placebo group no longer met criteria
for social phobia. In addition, there were significant effects
on all outcome measures such as lower levels of anxiety,
emotional distress, depression and better functioning in
work, social and family life. The training was made at a uni-
versity clinic, which theoretically could be a barrier for help
seeking since eye-contact and talking to authority figures is
a core problem for some of the sufferers. Hence, if the
treatment could be administered via the internet that could
open the door for millions of people in need. Another study
that also found positive outcomes was carried out bySchmidt and coworkers [18]. At termination, 72% of
patients in the active treatment condition, relative to 11%
of patients in the control condition, no longer met criteria
for social phobia. The results were maintained at 4-month
follow-up. Finally, McEvoy and Perini [19] have investigated
whether or not supplementing cognitive behavioral group
therapy (CBT) with attention training could potentiate
greater changes. It was tentatively concluded that while
supplementing CBT with attention training did not im-
prove outcomes, increasing attention control during CBT
was associated with symptom relief.
Another recent development in the treatment of social
anxiety disorder is the possibility to deliver CBT over the
Internet [20]. A large number of trials have found that
CBT delivered over the Internet can be as effective as face-
to-face CBT, even in direct comparison [21,22], and effects
have been documented by at least four independent re-
search groups in Australia [23,24], Spain [25], Sweden
[26,27], and Switzerland [28,29]. Given the two recent
developments and the fact that attention bias modification
is delivered via computer we decided to investigate if this
novel treatment could be delivered via the Internet with
no physical contact with the study participants. This has
been done once in a recent trial by Boettcher and co-
workers [30]. In fact, they could not replicate the promis-
ing results from the American studies. The aim of the
present study was to test if attention bias modification
delivered via the Internet was superior to a placebo condi-
tion (random attention training) in a group of participants
with diagnosed social anxiety disorder recruited from the
community. We hypothesized that the treatment would be
better than the control condition and that it would be
possible to present attention bias modification via the
Internet.
Methods
Participants and recruitment
The general procedure was similar to our previous rando-
mized controlled trials of internet-delivered self-help for
social anxiety disorder [27,30,31]. Participants were
recruited by media advertisements during the winter of
2009. A web page was created which included an outline
of the study as well as general information about social
anxiety disorder, the good results of the attention modifi-
cation program used in the USA [17,18], ethical issues,
internet security and a description of the study personnel.
Participants filled out an application form and a computer-
ized screening battery consisting of the Social Phobia
Screening Questionnaire (SPSQ; [32]), the self-rated ver-
sion of the Montgomery and Åsberg Depression Rating
Scale (MADRS–S; [33]), the remaining outcome measures
(see instruments below), and a few additional questions
regarding current and past treatments. To be included,
participants had to meet the following criteria: (a) a DSM–
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SPSQ; (b) scoring below 31 on the MADRS–S depression
scale and below 4 on the suicide item of this scale (to
prevent the inclusion of individuals in strong need of
specialist consultation); (c) not undergoing any other
psychological treatment during the study period; (d) if pre-
scribed drugs for anxiety or depression, the dosage had to
be constant for 2 months before the treatment onset and
kept constant throughout the study; (e) being at least
18 years old; (f) living in Sweden; (g) having access to a
computer with internet connection; (h) not having a hav-
ing a significant vision impairment, (i) not admitting an-
other serious or dominant disorder (e.g. psychosis,
substance misuse) that could be expected to influence the
outcome of the study; j) having a primary diagnosis of so-
cial anxiety disorder according to the Structured Clinical
Interview for DSM–IV Axis I Disorders (SCID–I; [34]).
The last criterion was evaluated by a telephone interview
in which the diagnostic questions from the social anxiety
disorder section of the SCID–I were posed. When a per-
son failed to meet the inclusion criteria, an individual
encrypted message was sent with advice on how and
where to seek more appropriate help.
As evident from the CONSORT flowchart (Figure 1), of
the 112 individuals who were assessed for eligibility 79 wereFigure 1 Flowchart of study participants, point of random assignmen
individuals with social phobia.subsequently included and randomized to attention modifi-
cation training or a placebo group. Demographic data on
the included participants are presented in Table 1.
Measures
The following social anxiety scales constituted the outcome
measures in the study: the Liebowitz Social Anxiety Scale
self-report version (LSAS-SR; [35,36]), the Social Phobia
Scale (SPS), the Social Interaction Anxiety Scale (SIAS;
[35]), and the Social Phobia Screening Questionnaire
(SPSQ; [32]). The LSAS-SR was the primary outcome
measure. In addition, the following secondary measures
were used to assess general anxiety and quality of life: the
Beck Anxiety Inventory (BAI; [37]), and the Quality of Life
Inventory (QOLI; [38]). In the screening phase the
Montgomery Åsberg Depression Rating Scale (MADRS-SR;
[33]) and the Alcohol Use Disorder Identification Test;
AUDIT [39]) was used. The outcome measures have good
psychometric properties even when administered via the
Internet [40,41]).
Treatment and placebo
Participants were either assigned to the real attention
modification program or to a placebo version. Everything
was identical in both conditions except for the locationt, and dropouts at each stage of a study of attention training in
Table 1 Demographic description of the participants at pre-treatment
Treatment (n=40) Placebo (n=39) Total (n=79)
Gender Female 26 (65.0%) 28 (71.8%) 54 (68.4%)
Male 14 (35.0%) 11 (28.2%) 25 (31.7%)
Age Mean (SD) 35.1 (13.3) 38.0 (12.0) 36.5 (12.7)
Marital status Married/living together 26 (65.0%) 18 (46.2%) 44 (55.7%)
Single 11 (27.5%) 16 (41.0%) 27 (34.2%)
Other 3 (7.5%) 5 (12.8%) 8 (10.1%)
Children Mean (SD) 1.0 (1.0) 0.5 (0.8) 0.8 (1.0)
Registered sick No 36 (90.0%) 36 (92.3%) 72 (91.1%)
Yes 4 (10.0%) 3 (7.7%) 7 (8.9%)
Social phobia Generalized 29 (72.5%) 30 (76.9%) 59 (74.7%)
Non-generalized 11 (27.5%) 9 (23.1%) 20 (25.3%)
Avoidant personality disorder (axis-II) Yes 14 (35.0%) 17 (43.6%) 31 (39.2%)
No 26 (65.0%) 22 (56.4%) 48 (60.8%)
Medication None 24 (60.0%) 21 (53.9%) 45 (57.0%)
Earlier 8 (20.0%) 9 (23.1%) 17 (21.5%)
Present 8 (20.0%) 9 (23.1%) 17 (21.5%)
Depression Mean (SD) 14.6 (7.1%) 14.7 (6.4%) 14.7 (6.7%)
AUDIT Mean (SD) 4.8 (3.5%) 4.3 (3.6%) 4.5 (3.5%)
Note: No significant differences existed between groups according to chi-2 and independent t-tests with Bonferroni correction for multiple tests.
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with a fixation cross (“+”) presented in the center of the
screen for 500 ms. Immediately following termination of
the fixation cue, the web based flash program in full
screen mode presented two faces of the same person,
one face on the top and one on the bottom, with each
pair displaying one of two combinations of emotions. Ei-
ther neutral-disgust, or neutral-neutral. After presenta-
tion of the faces for 500 ms, a probe appeared in the
location of one of the two faces. Participants were
instructed to indicate whether the probe was the letter E
or F by pressing the corresponding arrow on the key-
board using their dominant hand. The probe remained
on the screen until a response was given, after which the
next trial began. During each session, 160 trials with vari-
ous combinations of probe type (E/F), probe position
(top/bottom), face type (neutral/disgust) and person
(four male/four female were presented). There are a total
of 8 persons showing 2 different facial expressions; 4
male and 4 female showing disgust or neutral. In the real
condition the probe was always presented (100% of the
trials) at the location of the neutral face if there also was
a disgust face present (n = 128 trials). In contrast, in the
placebo condition the location of the probe could not be
predicted since the probe appeared with equal frequency
in the position of the disgust face and the neutral face.
The remaining 32 trials were neutral-neutral with the
probe randomly presented at the top/bottom. For a more
detailed description of the two conditions see Amir et al.[17]), since this study used the same procedures with the
exception that the material was presented via the
Internet.
Participants were encouraged to do the training on Tues-
days and Thursdays. They received an email and a SMS
reminding them to do the training on the training days. If a
session was missed a reminder was sent the following day.
The participants could only do the training between 5 AM
and 11 PM, and there should always be least one day be-
tween the sessions.Procedure and design
The participants were divided into two groups; treatment
or control by an online true random-number service in-
dependent of the investigators. The study protocol was
approved by the regional ethics committee, and written
informed consent was obtained from all participants by
surface mail.
All self-report scales were administered before the start of
the treatment. During the treatment LSAS-SR once a week
(Sundays). Following the four weeks of training LSAS-SR,
SPS, SIAS, SPSQ, MADRS-S and QOLI was readminis-
tered. Immediately following the training phase, a clinical
global impression of improvement (CGI-I) was mapped on
a 7-point scale CGI; [42]) after a telephone interview by a
blind assessor who had no earlier contact with the partici-
pants and no knowledge of to which group they had been
randomly allocated. Finally, to check if the effects were
Table 2 Immediate and four months follow-up results with intention-to-treat analysis using mixedeffect model
estimating means and (standard deviation) for all participants
Treatment (n=40) Placebo (n=39) Pairwise
comparison
Time
(F)
Interaction
(F)M (SD) M (SD)
Liebowitz Social Anxiety Scale, self-report 6.7*** 1.7
Week 0 73.8 (35.1) 73.0 (35.6) NS
Week 1 71.3 (35.1) 74.3 (35.6) NS
Week 2 67.4 (35.2) 66.4 (35.6) NS
Week 3 64.8 (35.4) 64.1 (35.6) NS
Week 4 66.0 (35.5) 60.5 (35.6) NS
4 months 68.6 (35.6) 66.1 (35.8) NS
Social Phobia Screening Questionnaire 32.9*** 0.6
Pre 31.9 (14.6) 33.3 (14.8) NS
Post 26.7 (14.8) 26.9 (14.8) NS
4 months 29.2 (14.9) 28.5 (15.0) NS
Social Phobia Scale 10.1*** 0.3
Pre 40.3 (25.4) 40.4 (25.7) NS
Post 35.9 (25.7) 34.2 (25.7) NS
4 months 36.6 (25.8) 35.4 (26.0) NS
Social Interaction Anxiety Scale 5.1** 0.3
Pre 50.6 (24.2) 53.1 (24.5) NS
Post 47.5 (24.5 48.7 (24.5) NS
4 months 47.6 (24.6) 49.0 (24.8) NS
Beck Anxiety Inventory 9.6*** 0.5
Pre 17.7 (12.8) 17.2 (12.9) NS
Post 15.3 (13.0) 13.4 (12.9) NS
4 months 16.2 (13.0) 14.1 (13.1) NS
Quality of Life Inventory 2.0 0.2
Pre 0.8 (2.5) 0.4 (2.5) NS
Post 1.1 (2.5) 0.6 (2.5) NS
4 months 1.0 (2.5) 0.6 (2.5) NS
*** p<.001; ** p<.01.
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the post-treatment assessment, conducted online by the re-
spective participant.
Analysis
In accordance with the intention-to-treat principle, all parti-
cipants were asked to complete post-treatment and follow-
up assessments, regardless of how many training sessions
they had completed. Independent t-tests and chi-2 were
used to check if randomization had resulted in a balanced
distribution across both conditions. As evident from
Figure 1, not all randomized participants provided complete
datasets. The lowest response rate was 94.9% (75/79) at
4 month follow-up. In order to handle missing data in an
intention-to-treat approach, we used a mixed models ap-
proach with a first-order autoregressive covariance structure
as suggested by Gueorguieva and Krystal [43]. The first-
order autoregressive covariance structure has the propertythat observations on the same subject that are closer in
time are more highly correlated than measurements at
times that are farther apart. Effect sizes (Cohen’s d) were
calculated with the estimated means from the mixed model
and by the following formula for converting standard error
to standard deviation: SD=SE*(sqrt(n)).
Results
Most participants (74 of 79) completed all 8 training session
for a mean of 7.8. Tables 1 and 2 show that randomization
resulted in a balanced distribution across both conditions at
pre-treatment. However, no interaction effects were identi-
fied suggesting that the treatment did not outperform the
placebo condition. This is echoed in the between-group ef-
fect size for the main outcome measure (LSAS-SR: Cohen’s
d=0.07; CI95% -0.29 to 0.23). Furthermore, the non-
significant planned pair wise comparisons suggested that
the treatment was without added value when controlling
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the use of a control condition. However, with the exception
of the Quality of Life Inventory there were significant over-
all time effects on all measures for both groups. But it
should be noted that the within-group effect sizes were
small (treatment d=0.15; placebo d=0.19).
Clinical significance
The CGI-I rating at post-treatment (n = 79) showed the
following non-significant results for the treatment group
vs. placebo group: very much improved (5.0% vs. 2.6%),
much improved (2.5% vs. 20.5%), small improvement
(32.5% vs. 35.9%), unchanged (57.5% vs. 38.5%) and small
deterioration (2.5% vs. 2.6%) (chi-2(4, N= 79) = 7.5;
p = 0.112). In addition to the self-report measures and
the blind CGI-I rating a SCID interview was conducted
with the results that three (7.5%) in the treatment group
and two (5.1%) in the placebo group no longer met
DSM-IV criteria for social phobia.
Treatment adherence
Of the 79 participants who commenced treatment 74
(93.7%) completed all 8 training sessions as scheduled.
However, five (6.3%) dropped out after only finishing
M=4.8 (SD=1.0) sessions.
An analysis of the proportion of correct trials revealed no
difference between the groups. The overall average was
M=98.7% correct indications of the letters presented. In
addition, there was no difference in the average response
time per trial M=733 ms (SD=290 ms).
Change in attention bias
To get a measure of attention bias we followed the sug-
gested procedure from the previous Amir study [17].
That included first eliminating response latencies for
inaccurate trials. This procedure resulted in the elimin-
ation of 1% of the trials. Change in attention bias was
subsequently calculated by subtracting response laten-
cies of trials where the probe preplaced a neutral face of
a disgust-neutral face pair from trial where both faces
were neutral. This bias has also been used by other in-
vestigator to index disengagement [44,45]. In addition,
response latencies less than 50 ms and greater than
1200 ms were considered outliers and were also elimi-
nated from the analysis. These ranges were determined
based on the inspection of the data using box plots and
resulted in eliminating 1% of the trials. We submitted
the participants’ performance on the Attention Task dur-
ing each session to a 2 × 8 (Group [treatment, control] ×
Time [session 1–8]) analysis of variance (ANOVA). This
analysis did not reveal a significant interaction of Group
X Time (F(7, 69) = 1.15, p = .327). However, when analyz-
ing the change scores on LSAS-SR there was a signifi-
cant, albeit weak, positive correlation, indicating that thehigher bias a participant had at the end of the treatment
the more that participant improved (r = .32, p< 0.006).
We calculated the correlation between session 1 bias
score and change in LSAS. This correlation was only sig-
nificant in the active group (r = 0.32, p< 005 active;
r =−0.14, p = 0.37 placebo group).
To assess whether participants remained blind to their
respective experimental condition, we asked the partici-
pants at post treatment whether they thought they had
received the active or the placebo intervention. Of the par-
ticipants who provided responses (n=76) 18.9% (7/37) in
the treatment group and 28.2% (11/39) in the placebo con-
dition thought they had been randomized to the treatment
program (Chi2(1, N=76) =0.9, p = .42).
Discussion
This was a double blind randomized controlled trial with
the aim to transfer the promising results of the Amir et al.
[17] and Schmidt et al. [18] studies to the Internet. Results
did not confirm our hypothesis that Internet-delivered at-
tention bias modification would be superior to a placebo
condition. However, there was a significant time effect, but
that is probably best explained by spontaneous remission
since both the treatment and the placebo group displayed
similar gains. In addition, the within group effect sizes were
small. This is the second randomized trial not being able to
replicate the initial promising results. However, the first
non-replication by Boettcher and coworkers was not identi-
cal to the original studies since different stimuli were used
[30]. Specifically, the two original studies used the emo-
tional facial expressions from Matsumoto and Ekman [46],
while Boettcher and colleges used the NimStim faces [47].
The procedure in the present study mirrored the Amir
study exactly including the same faces, number and spacing
of the trials, and the location and duration of the stimuli.
One obvious difference is that participants in the present
trial did the training in a home setting as opposed to a uni-
versity clinic ([17,18]). When looking at the proportion of
correctly identified probes there was no difference and the
marginally higher reaction time, as compared to Amir et al.
[17] is explained by how elimination of individual trials
were defined. The present study only excluded 3 SD above
the individual trial mean (apx 1600 ms), while Amir et al.
[17] simply excluded values higher than 1200 ms. More-
over, the method of delivery (i.e., internet based flash pro-
gram) vs. personal computer delivery was a difference
between current study and previous research.
An explanation of the null findings could be that this
study also included participants with non-generalized so-
cial phobia. However, the mean scores on LSAS-SR were
almost identical (73.4 in this trial compared to 74.5 in the
Amir trial). In addition, when running the analysis with
the NGSP and GSP groups separated, no differences in
the treatment effect emerged.
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where asked to predict condition the absolute majority
(81%) thought they had been randomized to the placebo
group. One would think that such a low level of positive
expectation would influence the trial. However, that can-
not explain the lack of effect since the Amir et al. [17]
and Schmidt et al. [18] papers reported almost identical
numbers (78% and 94% respectively). Hence, there is a
problem with the rationale and believability (cf.)[48].
However, the results when delivered on site have been
impressive. Possibly attention training at home is nega-
tively influenced by the fact that the person is sitting
calmly in the comfort of his or her home. Perhaps there
is an interaction between the active attention training
and the mild anxiety that participants with social anxiety
probably feel when they come to a university clinic to do
their training (cf.)[49]. Although we instructed the parti-
cipants to schedule the training when there would not
be disturbed, there is a possibility that short breaks or
non-focus reduces the effectiveness. Hence, the control
over the procedures and the setting before, during and
after training was suboptimal as compared to a lab.
There could of course also be cultural differences. For
example, in the case of panic disorder applied relaxation
seems to work well in Sweden, but maybe not in the
United Kingdom and USA [50,51]. The bias measure
used in this study can be criticized. It could be argued
that a task, in which the probe sometimes appears in the
position of the disgust face and sometimes in the pos-
ition of the neutral face, would be more accurate. How-
ever, Koster and coworkers [52] proposed that the probe
detection task may be modified such that vigilance for
threat and disengagement from threat may be assessed
by including baseline trials, i.e., trial with two neutral
faces. Using this new measure of bias, Koster et al.,
found that individuals with anxiety have had difficulty in
disengaging their attention from highly threatening pic-
tures. This measure of bias has been used but other
investigators to assess the specific componets of atten-
tional bias in anxiety [53-55. The largest limitation is
that participants were included without checking if they
indeed had an initial attentional bias [1]. This is a ser-
ious flaw since not all patients with presenting with anx-
iety show bias [5]. However, the presence of a bias was
not an inclusion criterion in the Amir et al. [17] or the
Schmidt et al. [18] studies. Since there were no inter-
action effects in terms of change in bias between the
two groups it can be concluded that not only was the
internet-based treatment in the present study unable to
modify attentional bias. In fact, there was the unex-
pected finding that larger bias was correlated with higher
improvement. However, it should be noted that this was
only a weak association, and could very well be
explained as a random replicable finding. Indeed, asHeeren and coworkers have shown, engagement towards
non-threat faces does not account for the positive treat-
ment effects [56]. It should be noted that the interven-
tion employed only trains attention away from
negativity. There could be added benefits of instead of
training what is essentially avoidance, to also or instead
train active selection of positive mood-supporting infor-
mation [57]. Perhaps the placebo condition, with equal
frequency in the position of the threatening and neutral
faces, is all that is needed to accomplish this disengage-
ment from threat. Hence, future studies could, if done in
an ethical way, test to include a condition of negative
training.
Conclusions
We conclude that attention bias modification may need
to be further investigated before dissemination for the
Internet.
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